ENTYVIO Pen
Vedolizumab · Takeda Pharmaceuticals America, Inc.
PRESCRIPTION ONLY (USA)ENTYVIO Pen ingredients
| Active ingredient | Strength |
|---|---|
| Vedolizumab | 108 mg/.68mL |
What ENTYVIO Pen is used for
ENTYVIO Pen is a specialist medicine (integrin receptor antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- ENTYVIO Pen
- Generic name
- Vedolizumab
- Made by
- Takeda Pharmaceuticals America, Inc.
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Integrin Receptor Antagonist
- FDA approval
- Biologic licence (BLA) BLA761133
- On the US market since
- 2023
Official information
- ENTYVIO Pen prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Vedolizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is ENTYVIO Pen?
ENTYVIO Pen (Vedolizumab) is a specialist medicine made by Takeda Pharmaceuticals America, Inc., approved by the US FDA.
What are the ingredients of ENTYVIO Pen?
ENTYVIO Pen contains Vedolizumab (108 mg/.68mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA